The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126668391 12666839 1 I 20160810 20160819 20160819 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-067950 BRISTOL MYERS SQUIBB 34.00 YR M Y 0.00000 20160819 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126668391 12666839 1 PS REYATAZ ATAZANAVIR SULFATE 1 Unknown 21567
126668391 12666839 2 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Unknown 0
126668391 12666839 3 SS ZIAGEN ABACAVIR SULFATE 1 Unknown U 0
126668391 12666839 4 SS RETROVIR ZIDOVUDINE 1 Unknown U 0
126668391 12666839 5 SS PREZISTA DARUNAVIR ETHANOLATE 1 Unknown U 0
126668391 12666839 6 SS CELSENTRI MARAVIROC 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126668391 12666839 1 HIV infection
126668391 12666839 2 HIV infection
126668391 12666839 3 HIV infection
126668391 12666839 4 HIV infection
126668391 12666839 5 HIV infection
126668391 12666839 6 HIV infection

Outcome of event

Event ID CASEID OUTC COD
126668391 12666839 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126668391 12666839 Drug resistance
126668391 12666839 Hepatitis B
126668391 12666839 Immune reconstitution inflammatory syndrome
126668391 12666839 Viral mutation identified

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found